Credit Suisse Maintains Neutral on Maxar Technologies, Lowers Price Target to $36
Credit Suisse analyst Robert Spingarn maintains Maxar Technologies (NYSE:MAXR) with a Neutral and lowers the price target from $47 to $36.
Canaccord Genuity Downgrades Maxar Technologies to Hold, Announces $40 Price Target
Canaccord Genuity analyst Ken Herbert downgrades Maxar Technologies (NYSE:MAXR) from Buy to Hold and announces $40 price target.
10 Stocks Moving In Wednesday’s After-Hours Session
Gainers
MercadoLibre (NASDAQ: MELI) shares are trading higher after the company reported Q2 EPS of $1.37, up from $1.11 year over year and better-than-expected Q2 sales results.
Maxar Technologies Q2 EPS $0.60, Adj. EBITDA $132M, Sales $473.00M Up From $439.00M YoY
Maxar Technologies (NYSE:MAXR) reported quarterly earnings of $0.60 per share. The company reported $473.00 million in sales this quarter. This is a 7.74 percent increase over sales of $439.00 million the same period
11 Industrials Stocks Moving In Wednesday’s After-Market Session
Gainers
Hudson Technologies (NASDAQ:HDSN) shares increased by 6.21% to $3.76 during Wednesday's after-market session. The company's market cap stands at $163.1 million. As per the news, the Q2 earnings report came out today.
Maxar Awarded Contract to Build New Satellite for SiriusXM
Maxar Technologies (NYSE:MAXR) (TSX:MAXR) today announced the company will manufacture a new geostationary communications satellite for longtime customer SiriusXM.
This press release features multimedia. View the full
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell
• UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.